test

Ron Rosenstraus

@Eversept Partners, Lp

Latest period2024 - Q3ReportedManaged Assets$1.46BTotal holdings67
Assets growth rate-0.03%Assets growth rate (2-Q avg)-1.3%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Eversept Partners, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 67 positions.

Assets under management

The assets under management (AUM) of Eversept Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.46B in assets, with a quarterly growth rate of -0.03% and a 2-quarter average growth rate of -1.3%. The portfolio is managed by Ron Rosenstraus, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TSVT2seventy Bio Inc
Recent Activity
Decreased -9.89%
0.33%
$4.711M
998,079 shares@ $4.73 avg price
BCRXBiocryst Pharmaceuticals Inc
Recent Activity
Decreased -53.54%
0.28%
$4.069M
535,405 shares@ $7.6 avg price
MOHMolina Healthcare Inc
Recent Activity
Decreased -42.06%
0.25%
$3.648M
10,588 shares@ $344.56 avg price
PBYIPuma Biotechnology Inc
Recent Activity
Decreased -2.64%
0.23%
$3.298M
1.293M shares@ $2.55 avg price
TRMLTourmaline Bio Inc
Recent Activity
Decreased -58.79%
0.15%
$2.169M
84,380 shares@ $25.72 avg price
AMRNAmarin Corp Plc
Recent Activity
Decreased -23.19%
0.15%
$2.075M
3.309M shares@ $0.63 avg price
NVRONevro Corp
Recent Activity
Decreased -37.16%
0.13%
$1.754M
313,780 shares@ $5.59 avg price
ALECAlector Inc
Recent Activity
Decreased -38.57%
0.11%
$1.551M
332,756 shares@ $4.67 avg price
AUTLAutolus Therapeutics Plc
Recent Activity
Decreased -33.44%
0.11%
$1.476M
406,558 shares@ $3.64 avg price
LQDALiquidia Corporation
Recent Activity
Decreased -63.07%
0.1%
$1.379M
137,949 shares@ $10.0 avg price